Large-scale plasmid DNA production is critical for applications in biotechnology and therapeutic development. However, many approaches require multiple steps and instruments during bacterial ...

North America dominated the viral vector & plasmid DNA manufacturing market with a revenue share in 2024. Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.

TORONTO--(BUSINESS WIRE)--Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA for use in genetic medicines, announced today that they have formed a partnership with ...

Catalent opened a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European Center of Excellence for Cell Therapies in Gosselies, Belgium. The facility, which contains over 12,000 ...

As a lab within the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutch, the Vector Production core assists investigators with the design, construction, and/or production of viral ...

Step into any laboratory that works with DNA, such as one creating genetic medicines, and there’s a good chance that you’ll find flasks filled with bacterial broths swirling away in oven-like ...